NEW YORK – Which articles gained the most attention from GenomeWeb’s readers last week? Here are the top five:
- Final FDA Guidance Lays Path for Drugmakers to Establish Circulating Tumor DNA as Trial Endpoint
- Oxford Nanopore Technologies Sues BGI, Affiliates for Sequencing Technology Contract Breach
- Polygenic Risk Scores Inch Towards Clinical Use in 2024
- New EU Project Focuses on Extracellular Vesicle Research, Diagnostics
- MiDiagnostics Closes €30M Series D Round Led by Thermo Fisher Scientific